Prosecution Insights
Prosecution Insights
4 pending office actions • 4 art units • 4 examiners • 4 of 4 (100%) have an AI response strategy ready
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 3 (75%) |
| No statute on record | 1 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BROWE, DAVID | 1 | 25.8% | +28.7% |
| SHIAO, REI TSANG | 1 | 80.0% | -34.5% |
| VALLE, ERNESTO | 1 | 60.0% | +33.3% |
| CHANG, KYUNG SOOK | 1 | 60.3% | +41.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18361142 | ORALLY DISINTEGRATING PALATABLE FORMULATIONS OF DROTAVERINE AND METHOD OF PREPARATION THEREOF | BROWE, DAVID | 39d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17910329 | CONTROLLED RELEASE FORMULATIONS COMPRISING DROTAVERINE OR SALT THEREOF | CHANG, KYUNG SOOK | 3d overdue |
| 18107619 | PHARMACEUTICAL COMBINATION OF ANTISPASMODIC AND ANXIOLYTIC AGENT | VALLE, ERNESTO | 12d |
| 18361142 | ORALLY DISINTEGRATING PALATABLE FORMULATIONS OF DROTAVERINE AND METHOD OF PREPARATION THEREOF | BROWE, DAVID | 39d |
| Art Unit | Apps |
|---|---|
| 1617 | 1 |
| 1691 | 1 |
| 1623 | 1 |
| 1613 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18361142 | ORALLY DISINTEGRATING PALATABLE FORMULATIONS OF DROTAVERINE AND METHOD OF PREPARATION THEREOF | BROWE, DAVID | 1617 | §103 | Non-Final OA | 39d | AI Ready | Jul 28, 2023 |
| 18361080 | STABLE PHARMACEUTICAL ORAL LIQUID FORMULATION OF AN ANTISPASMODIC AGENT | SHIAO, REI TSANG | 1691 | Other | Non-Final OA | 72d overdue | AI Ready | Jul 28, 2023 |
| 18107619 | PHARMACEUTICAL COMBINATION OF ANTISPASMODIC AND ANXIOLYTIC AGENT | VALLE, ERNESTO | 1623 | §103 | Non-Final OA | 12d | AI Ready | Feb 09, 2023 |
| 17910329 | CONTROLLED RELEASE FORMULATIONS COMPRISING DROTAVERINE OR SALT THEREOF | CHANG, KYUNG SOOK | 1613 | §103 | Final Rejection | 3d overdue | AI Ready | Sep 08, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial